- Barrons.com•5 hours ago
Yesterday, Gilead Sciences (GILD) announced better-than-forecast earnings but full-year sales guidance that fell short of analyst predictions, causing its shares to tumble. As result, expectations for ...
Medical stocks are once again expected be among the better performers in Q2. Johnson & Johnson (JNJ) and Biogen have already set the tone with beats and raised outlooks.
|Bid||62.35 x 1000|
|Ask||62.39 x 500|
|52wk Range||26.41 - 63.35|
|Day's Range||62.35 - 63.20|
|Avg Vol (3m)||2,756,107|
As of 2:54 PM EDT. NasdaqGS Real Time Price. Market open.